CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
NET (LOSS) ATTRIBUTABLE TO MANHATTAN SCIENTIFICS, INC.	$ (1,182,000)	$ (1,896,000)
Net (loss) attributable to noncontrolling interest	(472,000)
Adjustments to reconcile net income/(loss) to net cash provided by (used in) operating activities:
Stock options issued/vested for services		60,000
Depreciation and amortization	250,000	240,000
Changes in operating assets and liabilities:
Accounts receivable	30,000
Accounts payable and accrued expenses	237,000	157,000
Net cash provided by/(used in) operating activities	(1,137,000)	(1,439,000)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of fixed assets	(23,000)
Net cash used in investing activities	(23,000)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from note payable - related party	65,000
Payments on notes payable other	(1,935,000)
Proceeds from issuance of common stock	4,705,000
Net cash (used in)/provided by financing activities	2,835,000
NET INCREASE IN CASH AND CASH EQUIVALENTS	1,675,000	(1,439,000)
Cash and cash equivalents, beginning of year	1,068,000	5,364,000
CASH AND CASH EQUIVALENTS, END OF YEAR	2,743,000	3,925,000
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid
Income taxes paid
SUPPLEMENTAL DISCLOSURES OF NONCASH INVESTING AND FINANCING ACTIVITIES:
Issuance of common stock for prepaid services
Beneficial conversion feature associated with debt